26DPP01283 - T3165 - NALOXONE, 4MG NASAL SPRAY, FDA-APPROVED, FOR THE NEW JERSEY DEPARTMENT OF HUMAN SERVICES' NALOXONE DIRECT PROGRAM RFP
Posted
-
Oct 27, 2026
This RFP is for the procurement of FDA-approved Naloxone, 4mg Nasal Spray, for the New Jersey Department of Human Services' Naloxone Direct Program.
